department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Tavneos · pharmadog

pharmadog
drugs
Tavneos

drug

patient view →

avacopan

Marketedupdated 2mo ago

by ChemoCentryx Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Tavneos

generic

avacopan

indication

Granulomatosis with Polyangiitis (Wegener's Granulomatosis)

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 7, 2026

92 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Nov 27, 2039compositionUS 11603356
Nov 27, 2039formulationUS 11951214
Jan 6, 2034compositionUS 8906938
Feb 3, 2031compositionUS 84455154.6y

FDA exclusivities (2)

Oct 7, 2028ODE-377Orphan Drug (7y)2.3y
Oct 7, 2026NCENew Chemical Entity (5y)92d

Data sources

ClinicalTrials.gov

last refreshed 2m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying avacopan

phase4A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitisrecruitingn=300
phase3Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.recruitingn=20
phase1A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)completedn=13
phase3TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitisnot yet recruitingn=30
phase4Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitisrecruitingn=160
phase3A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitiscompletedn=331
phase2Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)completedn=435
phase2Controlled Trial Evaluating Avacopan in C3 Glomerulopathycompletedn=57

more trials →